Current role
Hagop Youssoufian, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Hagop Youssoufian, M.D.
C4 Therapeutics, Inc. reported in an 8-K filed February 2, 2023 that Hagop Youssoufian, M.D. was appointed interim Chief Medical Officer, effective February 24, 2023.
“In connection with Dr. Crystal's upcoming departure, the Company has engaged Hagop Youssoufian, M.D. as a clinical development consultant and, upon Dr. Crystal's departure, as the Company's interim Chief Medical Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
C4 Therapeutics, Inc. (CCCC)
SEC 8-K
Current2023-02-24–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at C4 Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Andrew J. Hirsch CEO
- Andrew Phillips CEO
- Ron Cooper Chairman, Board Member
- Kendra R. Adams CFO, Chief Accounting Officer
- Lauren White Chief Accounting Officer
- Mark Mossler Chief Accounting Officer
- William T. McKee Chief Accounting Officer
- Adam S. Crystal Board Member
- Donna Grogan, M.D. Board Member
- Laura Bessen, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.